Entering text into the input field will update the search result below

Edwards Lifesciences prevails in challenge to Boston Sci valve patent

  • Edwards Lifesciences (NYSE:EW) has prevailed in an Inter Partes Review of Boston Scientific's (BSX) U.S. Patent No. 8,992,608 covering its transcatheter heart valve. The USPTO ruled that the all claims under the patent are invalid.
  • BSX filed infringement litigation in 2016. Edwards returned the favor and filed infringement litigation against BSX related to three patents protecting its transcatheter valve. A ruling is expected later this year.

Recommended For You

About EW Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EW--
Edwards Lifesciences Corporation